Canine CEA antibody and antigen (recombinant protein)
Diagnostic anti-Canine CEA antibodies pairs and antigen for animal health (animal Dog/Canine breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-CAN-CEA-Ag01 | Recombinant Canine CEA protein | 3090 |
GMP-CAN-CEA-Ab01 | Anti-Canine CEA mouse monoclonal antibody (mAb) | 1953 |
GMP-CAN-CEA-Ab02 | Anti-Canine CEA mouse monoclonal antibody (mAb) | 1953 |
GMP-CAN-CEA-Ab03 | Anti-Canine CEA human monoclonal antibody (mAb) | 1953 |
GMP-CAN-CEA-Ab04 | Anti-Canine CEA human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-CAN-CEA-Ag01 |
Product Name | Recombinant Canine CEA protein |
Target/Biomarker | Canine carcinoembryonic antigen (AGP) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Canine carcinoembryonic antigen antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in AGP level test of animal Dog/Canine with breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer. |
Tag | His |
Products description | Recombinant Canine CEA protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-CAN-CEA-Ab01, GMP-CAN-CEA-Ab02 |
Product Name | Anti-Canine CEA mouse monoclonal antibody (mAb) |
Target/Biomarker | Canine carcinoembryonic antigen (AGP) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Canine carcinoembryonic antigen antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AGP antibodies in AGP level test of animal Dog/Canine with breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer. |
Tag | mFc |
Products description | Anti-Canine CEA mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AGP antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-CAN-CEA-Ab03, GMP-CAN-CEA-Ab04 |
Product Name | Anti-Canine CEA human monoclonal antibody (mAb) |
Target/Biomarker | Canine carcinoembryonic antigen (AGP) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Canine carcinoembryonic antigen antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AGP antibodies in AGP level test of animal Dog/Canine with breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer. |
Tag | hFc |
Products description | Anti-Canine CEA human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AGP antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Carcinoembryonic Antigen (CEA) in dogs (canines) is a glycoprotein biomarker that belongs to the immunoglobulin superfamily of cell adhesion molecules. This protein plays a multifaceted role in both normal physiology and disease states. During fetal development, CEA is actively produced and is involved in crucial cell adhesion processes, promoting tissue formation and integrity. However, in healthy adult dogs, CEA is typically present at very low levels. The structure of CEA is characterized by multiple immunoglobulin-like domains, making it adept at facilitating cell adhesion. Its primary function is to mediate interactions between cells, ensuring proper tissue organization during embryonic growth. In adult dogs, CEA's expression is significantly reduced but can become elevated in certain pathological conditions.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.